Clinical trial
A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced…
NCT00122291 · Alberta Health services, Other · Unknown status
Key facts
| NCT number | NCT00122291 |
|---|---|
| Title | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer |
| Official title | A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer |
| Lead sponsor | Alberta Health services, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer, Neoplasm Metastasis |
| Intervention type | Drug, Procedure |
| Interventions | Capecitabine, Pelvic radiation |
| Enrollment | 66 |
| Start date | Jan 1, 2002 |
| First posted | Jul 22, 2005 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: